Uncategorized Where Does The Future Lies In The Chinese CAR-T Market?

Where Does The Future Lies In The Chinese CAR-T Market?

In 2017, a series of events have drawn national and international attentions to CAR-T therapy, making it one of the hottest topic of the year. In January, Shanghai Fosun and Kite Pharma has formed a joint venture, with each holding 50% stake. In February, Juno has announced to discontinue its JCAR015 trail and began to …

Read Article Read More

Uncategorized The 4 Trends of In Vitro Diagnostics in China

The 4 Trends of In Vitro Diagnostics in China

In recent years, merger and acquisition (M&A) has been the dominant theme in the Chinese healthcare and pharmaceutical industry, especially in the field of in vitro diagnostics (IVD). A number of companies have undergone acquisitions and this trend will continue to grow in 2018. This integration phenomenon has raised new requirements and challenges for large customer-oriented central …

Read Article Read More

Uncategorized The Liquid Biopsy Market in The Past 5 Years: China VS U.S.

The Liquid Biopsy Market in The Past 5 Years: China VS U.S.

  According to World Health Organization, cancer is the second leading cause of death globally in the past decade; however, it is rapidly gaining ground as the No.1 killer. About 14 million new cases emerge annually worldwide, which results in around 8.8 million deaths yearly — a mortality rate as high as 63%! Although cancer …

Read Article Read More

Uncategorized The Rise of China ‘s Biotechnology and Pharmaceutical Industry

The Rise of China ‘s Biotechnology and Pharmaceutical Industry

The American Society of Clinical Oncology (ASCO) conference, the biggest global annual event of cancer research, is considered as the “Super Bowl” of the pharmaceutical and biotechnology industry. Every year, people from all over the world come here to showcase their most promising clinical trial data to the public, no matter they are major pharma …

Read Article Read More

Uncategorized China officially joined the ICH, marking its real integration into the international drug regulatory system

China officially joined the ICH, marking its real integration into the international drug regulatory system

Recently, China Food and Drug Administration (CFDA) has submitted its membership application to the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (also known as the International Council for Harmonisation or ICH), marked its integration into the internationally recognized regulatory system. ICH was co-launched by regulatory agencies and industry associations from …

Read Article Read More

The Chinese Pharmaceutical Industry- updates and analysis The Three Major Trends of The Chinese Healthcare Industry Reform in the Next 10

The Three Major Trends of The Chinese Healthcare Industry Reform in the Next 10

In the past decade, medication sale has accounted for the majority of the revenue in the Chinese healthcare system, which has become an urgent issue. The Chinese government is under great pressures to bring immediate changes and turn the tide. In the wake of this phenomenon, it is predicted that three major trends will happen, …

Read Article Read More

Uncategorized The pharmaceutical consultant of the Chinese market – Jin Zhang

The pharmaceutical consultant of the Chinese market – Jin Zhang

Your guide of the Chinese pharmaceutical industry Please feel free to contact me about any questions of the Chinese pharmaceutical market! I am the pharmaceutical consultant for China! Thank you for coming to my blog! I am the pharmaceutical consultant of the Chinese pharmaceutical and healthcare industry. If you are interested in learning more and …

Read Article Read More